Missouri’s plans to use the anesthetic propofol in executions may face new delays.
In May, Missouri announced it was switching to propofol after sodium thiopental, another drug commonly used in executions, became harder to acquire. But, Fresenius Kabi USA, one of propofol’s two domestic suppliers, announced last week it was instructing its distributors not to fill orders from departments of corrections in the United States.
This week: NBAF opponents are gaining strength in their fight against the Disease Laboratory. Plus, the American Soybean Association is looking for fewer restrictions from the European Union on genetically modified soybeans.
The American Soybean Association is pushing for U.S. trade representatives to negotiate better trading terms with Europe, looking for the European Union to ease the strict restrictions it imposes on genetically modified soybeans. The group petitioned a U.S. trade representative who is part of a new working group with the European Union to work on its behalf.
We’ll see how the next couple weeks are vital for the European Union, and how this will affect Mid-Missouri. Plus, we’ll dig a little deeper into the ongoing story about Mamtek and how this affects other cities in Missouri.